P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

Each week, we present a journal club in which we choose a study that we believe will be of interest to the interventional cardiology community and discuss it at a virtual journal club with several of our faculty members.

Panelists

Allen Jeremias
David Cohen
Evan Shlofmitz
Ziad Ali

Presenter

Jeffrey  Moses
Roxana Mehran

Previous PostComprehensive Radiation Shield Minimizes Operator Radiation Exposure and Obviates Need for Lead Aprons
Next PostThe Age of Ultreon 2.0: AI Powered OCT-Guided PCI

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

Panelists

Presenter

Previous PostComprehensive Radiation Shield Minimizes Operator Radiation Exposure and Obviates Need for Lead Aprons

Next PostThe Age of Ultreon 2.0: AI Powered OCT-Guided PCI